Rite Aid

Rite Aid Corp. engages in the ownership and management of retail drug stores. It operates through following segments: Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment includes branded and generic prescription drugs, health and beauty aids, personal care products, and walk-in retail clinics. The Pharmacy Services segment offers transparent and traditional pharmacy benefit management for insurance companies, employers, health plans, and government employee groups. The company was founded by Alex Grass on September 12, 1962 and is headquartered in Philadelphia, PA.

Earnings data Q1 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Rite Aid is a drugstore chain that offers prescription medications, over-the-counter drugs, and health and wellness products. Rite Aid is reshaping the concept of a modern pharmacy by catering to customer demands through various convenient channels, including retail and delivery pharmacy services. Additionally, the company's offerings extend to services provided by its wholly-owned subsidiaries, namely Elixir, Bartell Drugs, and Health Dialog. Elixir, Rite Aid’s pharmacy benefits and services company, encompasses accredited mail and specialty pharmacies, prescription discount programs, and an advanced adjudication platform. These components combine to provide exceptional member experiences and substantial cost savings. Furthermore, Health Dialog delivers healthcare coaching and disease management services through interactive live online sessions and phone-based health services.

Rite Aid is a health products and services company with 2,400 locations across 17 states.

The company's omnichannel business includes digital, retail, and delivery touchpoints. Rite Aid is a top 20 seller of speciality medications, per its investor website.

In addition to its retail business, Rite Aid owns a pharmacy benefits subdivision (Elixir) and a personalized health services and coaching arm, Health Dialog, which has served 10MM members as of May 2022.

The company has reported $1.85 billion of liquidity with no debt maturities until 2025. According to its investor website, Rite Aid expects to be free cash flow (FCF) positive in FY23.

In Q2 2022, Rite Aid shared a three-part growth strategy aimed at deepening market share, expanding into new markets, and creating new offerings.

To grow the current business, Rite Aid is aiming to increase its e-commerce and digital sales, refresh its loyalty program, and grow its specialty pharmacy offering, which focuses on serving customers with complex health conditions.

New market expansion plans include increasing Rite Aid's footprint of "small format" pharmacies in underserved communities and implementing "store within a store" partnerships.

Rite Aid also aims to grow via new offerings, such as expanded health plan and health system clinical services, a pharmacy benefit manager (PBM) as a service offering, and new strategic partnerships.

Rite Aid Investor Relations

*This is not investment advice.

CVS Health

JPMorgan Chase & Co

Walgreens

Herbalife

Pharmacies & Drug Stores Industry Outlook: Prospects Mixed

Rite Aid is still a risky play, but the technicals finally look attractive and the fundamentals are improving for RAD stock. 
The post It’s Super Speculative, but RAD Stock May Actually Be a Buy appeared first on InvestorPlace.

It’s Super Speculative, but RAD Stock May Actually Be a Buy

Cardtronics

Expanding on an existing ATM branding and ATM management relationship with Cardtronics, TD Bank increases presence in one of the nation’s most competitive banking markets Expanding on an existing ATM branding and ATM management relationship with Cardtronics, TD Bank increases presence in one of the nation’s most competitive banking markets

TD Bank Expands ATM Network to include 80 Rite Aid Stores across New York City in Partnership with Cardtronics

Rite Aid shares have been seized with volatility, making RAD stock a toss-up play for bears and bulls alike.
The post Rite Aid Stock Could Break $14 Resistance, Or $11 Support appeared first on InvestorPlace.

Rite Aid Stock Could Break $14 Resistance, Or $11 Support

Outside of another short squeeze, it's tough to see RAD stock going higher long-term. Even after the rally, shares remain a sell.

After Last Month’s Epic Rally, Rite Aid Stock Could Go Lower

RAD stock appears like an interesting bet considering its present market discount. However, speculators should be aware that the company’s financial health leaves much to be desired.

Investors Will See What They Want in RAD Stock

Rite Aid Corporation (NYSE:RAD) could deliver a successful stock price turnaround, in my opinion, following its 34% decline in the past year.

Why Rite Aid Has Recovery Potential

Everi

Focus Financial Partners

Forterra

Performance Food Group

Fabulous economic data confirms U.S. economic stability and clearly indicates that the expansionary phase is here to stay.

Strong Economic Data Bolster Longest U.S. Expansion: 5 Picks

Rite Aid (RAD) reported earnings 30 days ago. What's next for the stock?

Rite Aid (RAD) Up 6.4% Since Last Earnings Report: Can It Continue?

The Rite Aid Board Prescription: Complete The Director Refill

Although Rite Aid stock has come a long way, the reality is that the fundamental picture is incredibly messy. Management must reveal more substance before investors have any confidence in the beleaguered company.

To Stay at $20, Rite Aid’s Got to Do More

Eros

HEXO Corp

iQIYI

Cenntro Electric Group

While markets may roar to all-time highs in 2020, these five stocks likely will miss the party and are stocks to sell in the new year.

5 Not-So-Hot Stocks to Sell in 2020

Rite Aid's (RAD) sound fundamentals and strategic endeavors might help it retain its bull run in 2020. Wellness remodels, the expansion of EnvisionRxOptions and innovative products are keys to growth.

Why Rite Aid (RAD) is Poised for Splendid Returns in 2020

Arcos Dorados Hlds

Genesco

Hibbett Sports

Retailers have been benefiting from their concerted endeavors in product innovation, introduction of new styles, merchandise replenishment and store refurbishments.

5 Top Retail Stocks Set to Surge in 2020 After a Solid 2019

Bargains in the health-care sector like RAD stock don't come along all that often. It's time to go against the grain and pick up some shares.

Rite Aid Stock Is a Bottom Fisher’s Paradise at Its Current Price

AmerisourceBergen

Cardinal Health

Johnson & Johnson

McKesson

Teva Pharmaceutical

Several companies might have to pay out $48 billion or more.

Multi-Billion Dollar Opioid Litigation Targets Drug Companies, Drugstores, and Maybe Doctors

The drugstores allege it was the doctors who prescribed the pills who should shoulder the culpability for the opioid crisis.

CVS, Walgreens, And Rite Aid Sue Doctors In Latest Move In Federal Opioid Case

RAD stock nearly tripled in the last month of 2019, but Rite Aid stock subsequently fell and looks poised for more declines.
The post Don’t Be Fooled by the Big Spike of Rite Aid Stock appeared first on InvestorPlace.

Don’t Be Fooled by the Big Spike of Rite Aid Stock

The company needs the right traffic-driving plans and flawless execution.

Rite Aid Should Use These 2 Strategies to Fuel Its Turnaround

Amarin Corporation Plc

Domino's Pizza

iRobot

Shopify

Target

Under Armour

The M&A market could bounce-back in 2020, and as it does, investors should keep an eye on these seven buyout targets.

7 Buyout Targets to Watch For 2020

Beaten-down pharmacy chain stocks could enter new uptrends in the coming months.

Pharmacy Chains Could Reward Bottom Fishers in 2020

With a heavy debt load and mounting competition, Rite Aid stock is looking like one to avoid as we begin 2020.
The post Rite Aid Stock Is Still One of the Top Stocks to Avoid in 2020 appeared first on InvestorPlace.

Rite Aid Stock Is Still One of the Top Stocks to Avoid in 2020

Rite Aid: Time To Book Some Profits

The buying stampede for Rite Aid stock continued on Friday, more than a week after the drugstore chain's third-quarter earnings sparked an epic run.
The post This Unlikely Stock Has Exploded In Just The Last Week appeared first on Investor's Business Daily.

This Unlikely Stock Has Exploded In Just The Last Week

Rite Aid is having quite a happy holiday. The company's stock has nearly tripled in 9 days after the drug store shocked investors with much-better-than-expected earnings.

News for Rite Aid Stock (RAD)